Professional Summary »
Practice Locations »
Referring Physicians »
Biography
Professional Summary
Education & Certifications
- Board Certification: American Board of Internal Medicine, Advanced Heart Failure and Transplant Cardiology (2022)
- Fellowship: Stanford University Advanced Heart Failure and Transplant Fellowship (2022) CA
- Board Certification: American Board of Internal Medicine, Cardiovascular Disease (2020)
- Fellowship, Beth Israel Deaconess Medical Center Harvard Medical School, MA (2020)
- Board Certification: American Board of Internal Medicine, Internal Medicine (2017)
- Residency: Massachusetts General Hospital Internal Medicine Residency (2017) MA
- Medical Education: Northwestern University Feinberg School of Medicine (2014) IL
Publications
-
Proteomic profiling reveals novel biomarkers and pathways in yype 2 diabetes risk.
Ngo, D., Benson, M. D., Long, J. Z., Chen, Z.-Z. Z., Wang, R., Nath, A. K., … Gerszten, R. E. (2021). Proteomic profiling reveals novel biomarkers and pathways in yype 2 diabetes risk. JCI Insight. -
Proteomics in Heart Failure: From Benchtop to Bedside.
Katz, D. H., & Thompson, A. D. (1800). Proteomics in Heart Failure: From Benchtop to Bedside. Journal of Cardiac Failure. -
Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease.
Katz, D. H., Tahir, U. A., Bick, A. G., Pampana, A., Ngo, D., Benson, M. D., … Gerszten, R. E. (2022). Whole Genome Sequence Analysis of the Plasma Proteome in Black Adults Provides Novel Insights Into Cardiovascular Disease. Circulation, 145(5), 357–370. -
Human plasma proteomic profiles indicative of cardiorespiratory fitness (vol 3, pg 786, 2021)
Robbins, J. M., Peterson, B., Schranner, D., Tahir, U. A., Rienmuller, T., Deng, S., … Gerszten, R. E. (2021). Human plasma proteomic profiles indicative of cardiorespiratory fitness (vol 3, pg 786, 2021). NATURE METABOLISM, 3(9), 1275. -
Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults
Katz, D. H., Tahir, U. A., Ngo, D., Benson, M. D., Gao, Y., Shi, X., … Gerszten, R. E. (2021). Multiomic Profiling in Black and White Populations Reveals Novel Candidate Pathways in Left Ventricular Hypertrophy and Incident Heart Failure Specific to Black Adults. CIRCULATION-GENOMIC AND PRECISION MEDICINE, 14(3), 348–358. -
Human plasma proteomic profiles indicative of cardiorespiratory fitness
Robbins, J. M., Peterson, B., Schranner, D., Tahir, U. A., Rienmueller, T., Deng, S., … Gerszten, R. E. (2021). Human plasma proteomic profiles indicative of cardiorespiratory fitness. NATURE METABOLISM, 3(6), 786-+. -
Metabolomic Profiles and Heart Failure Risk in Black Adults: Insights From the Jackson Heart Study
Tahir, U. A., Katz, D. H., Zhao, T., Ngo, D., Cruz, D. E., Robbins, J. M., … Gerszten, R. E. (2021). Metabolomic Profiles and Heart Failure Risk in Black Adults: Insights From the Jackson Heart Study. CIRCULATION-HEART FAILURE, 14(1), 28–38. -
Circulating testican-2 is a podocyte-derived marker of kidney health
Ngo, D., Wen, D., Gao, Y., Keyes, M. J., Drury, E. R., Katz, D. H., … Rhee, E. P. (2020). Circulating testican-2 is a podocyte-derived marker of kidney health. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 117(40), 25026–25035. -
Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19.
Katz, D. H., Tahir, U. A., Ngo, D., Benson, M. D., Bick, A. G., Pampana, A., … Gerszten, R. E. (2020). Proteomic Profiling in Biracial Cohorts Implicates DC-SIGN as a Mediator of Genetic Risk in COVID-19. MedRxiv : the Preprint Server for Health Sciences. -
In the Clinic Stable Ischemic Heart Disease
Katz, D., & Gavin, M. C. (2019). In the Clinic Stable Ischemic Heart Disease. ANNALS OF INTERNAL MEDICINE, 171(3), ITC17–U136. -
A Role for Branched-Chain Amino Acids in the Pathophysiology of Diabetes: Using Data to Guide Discovery
Katz, D. H., & Gerszten, R. E. (2018). A Role for Branched-Chain Amino Acids in the Pathophysiology of Diabetes: Using Data to Guide Discovery. CLINICAL CHEMISTRY, 64(8), 1250–1251. -
Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction
Katz, D. H., Deo, R. C., Aguilar, F. G., Selvaraj, S., Martinez, E. E., Beussink-Nelson, L., … Shah, S. J. (2017). Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 10(3), 275–284. -
Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN Study
Aguilar, F. G., Selvaraj, S., Martinez, E. E., Katz, D. H., Beussink, L., Kim, K.-Y. A., … Shah, S. J. (2016). Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN Study. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 33(3), 386–397. -
Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction
Klein, D. A., Katz, D. H., Beussink-Nelson, L., Sanchez, C. L., Strzelczyk, T. A., & Shah, S. J. (2015). Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction. AMERICAN JOURNAL OF CARDIOLOGY, 116(7), 1093–1100. -
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., … Deo, R. C. (2015). Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction. CIRCULATION, 131(3), 269-+. -
Albuminuria Is Independently Associated With Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection Fraction
Katz, D. H., Burns, J. A., Aguilar, F. G., Beussink, L., & Shah, S. J. (2014). Albuminuria Is Independently Associated With Cardiac Remodeling, Abnormal Right and Left Ventricular Function, and Worse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC-HEART FAILURE, 2(6), 586–596. -
Addressing Statin Adverse Effects in the Clinic: The 5 Ms
Katz, D. H., Intwala, S. S., & Stone, N. J. (2014). Addressing Statin Adverse Effects in the Clinic: The 5 Ms. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 19(6), 533–542. -
Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction
Shah, S. J., Katz, D. H., & Deo, R. C. (2014). Phenotypic Spectrum of Heart Failure with Preserved Ejection Fraction. HEART FAILURE CLINICS, 10(3), 407-+. -
Aggressive Lipid Management in Very Elderly Adults: Less Is More Response
Stone, N. J., Intwala, S., & Katz, D. (2014). Aggressive Lipid Management in Very Elderly Adults: Less Is More Response. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 62(5), 947–948. -
Statins in Very Elderly Adults (Debate)
Stone, N. J., Intwala, S., & Katz, D. (2014). Statins in Very Elderly Adults (Debate). JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 62(5), 943–945. -
Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction
Burke, M. A., Katz, D. H., Beussink, L., Selvaraj, S., Gupta, D. K., Fox, J., … Shah, S. J. (2014). Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction. CIRCULATION-HEART FAILURE, 7(2), 288–299. -
Association of Low-Grade Albuminuria With Adverse Cardiac Mechanics Findings From the Hypertension Genetic Epidemiology Network (HyperGEN) Study
Katz, D. H., Selvaraj, S., Aguilar, F. G., Martinez, E. E., Beussink, L., Kim, K.-Y. A., … Shah, S. J. (2014). Association of Low-Grade Albuminuria With Adverse Cardiac Mechanics Findings From the Hypertension Genetic Epidemiology Network (HyperGEN) Study. CIRCULATION, 129(1), 42-+. -
Prevalence, Clinical Characteristics, and Outcomes Associated With Eccentric Versus Concentric Left Ventricular Hypertrophy in Heart Failure With Preserved Ejection Fraction
Katz, D. H., Beussink, L., Sauer, A. J., Freed, B. H., Burke, M. A., & Shah, S. J. (2013). Prevalence, Clinical Characteristics, and Outcomes Associated With Eccentric Versus Concentric Left Ventricular Hypertrophy in Heart Failure With Preserved Ejection Fraction. AMERICAN JOURNAL OF CARDIOLOGY, 112(8), 1158–1164. -
Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing.
Austin, T. R., McHugh, C. P., Brody, J. A., Bis, J. C., Sitlani, C. M., Bartz, T. M., … Psaty, B. M. (2022). Proteomics and Population Biology in the Cardiovascular Health Study (CHS): design of a study with mentored access and active data sharing. European Journal of Epidemiology. -
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals.
Tahir, U. A., Katz, D. H., Avila-Pachecho, J., Bick, A. G., Pampana, A., Robbins, J. M., … Gerszten, R. E. (2022). Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals. Nature Communications, 13(1), 4923. -
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods
Katz, D. H., Robbins, J. M., Deng, S., Tahir, U. A., Bick, A. G., Pampana, A., … Gerszten, R. E. (2022). Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods. SCIENCE ADVANCES, 8(33), eabm5164. -
Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans.
Chen, Z.-Z., Pacheco, J. A., Gao, Y., Deng, S., Peterson, B., Shi, X., … Gerszten, R. E. (2022). Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans. Diabetes. -
Mining a GWAS of Severe Covid-19
Katz, D. H., Wilson, J. G., & Gerszten, R. E. (2020). Mining a GWAS of Severe Covid-19. New England Journal of Medicine, 383. -
Plasma proteomic changes in response to exercise training are associated with cardiorespiratory fitness adaptations.
Robbins, J. M., Rao, P., Deng, S., Keyes, M. J., Tahir, U. A., Katz, D. H., … Gerszten, R. E. (2023). Plasma proteomic changes in response to exercise training are associated with cardiorespiratory fitness adaptations. JCI Insight, 8(7).
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Mechanical Circulatory Support Program Stanford, CA
Stanford, CA
Mechanical Circulatory Support Program
300 Pasteur Drive , 2nd Floor, Room A260
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Heart Failure Clinic in Pleasanton Pleasanton, CA
Pleasanton, CA
Heart Failure Clinic in Pleasanton
5565 W. Las Positas Blvd., Suite 150
Pleasanton , CA 94588
Make An Appointment More Clinic Information » Getting Here »Heart Transplant Program Stanford, CA
Stanford, CA
Heart Transplant Program
300 Pasteur Drive , 2nd Floor, Room A21
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Heart & Vascular Clinic Pleasanton Pleasanton, CA
Pleasanton, CA
Heart & Vascular Clinic Pleasanton
5565 W. Las Positas Blvd., Suite 150
Pleasanton , CA 94588
Make An Appointment More Clinic Information » Getting Here »Heart Failure Clinic at Stanford Stanford, CA
Stanford, CA
Heart Failure Clinic at Stanford
300 Pasteur Drive , 2nd Floor, Room A260
Stanford , CA 94305
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records